U.S. Pharmaceutical Dissolution Testing Services Market (2025 - 2033 ) Size, Share & Trends Analysis Report By Method (In Vitro, In Vivo), By Dosage Form (Capsules, Tablets), By Dissolution Apparatus (Basket, Paddle), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Value chain based analysis (Model 2)
                        1.7.3. Multivariate Analysis (Model 3)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Pharmaceutical Dissolution Testing Services Market: Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. U.S. Pharmaceutical Dissolution Testing Services Market Dynamics
                        3.2.1. Market Driver Impact Analysis
                            3.2.1.1. Increasing R&D activities
                            3.2.1.2. Rising burden of chronic and infectious diseases supporting demand for dissolution testing of drugs
                            3.2.1.3. Rising use of generic drugs
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Increased effort for method validation
                    3.3. Technological Landscape
                    3.4. Pricing Model Analysis
                    3.5. 3.2. U.S. Pharmaceutical Dissolution Testing Services Market: Analysis Tools
                        3.5.1. Porter’s Five Forces Analysis
                        3.5.2. PESTEL Analysis
Chapter 4. U.S. Pharmaceutical Dissolution Testing Services Market: Method Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Pharmaceutical Dissolution Testing Services Market Movement Analysis
                    4.3. U.S. Pharmaceutical Dissolution Testing Services Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
                    4.4. In Vitro
                        4.4.1. In Vitro Market Estimates and Forecasts, 2021 - 2033 (USD million)
                    4.5. In vivo
                        4.5.1. In Vivo Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Pharmaceutical Dissolution Testing Services Market: Dosage Form Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Pharmaceutical Dissolution Testing Services Market Movement Analysis
                    5.3. U.S. Pharmaceutical Dissolution Testing Services Market Size & Trend Analysis, by Dosage form, 2021 to 2033 (USD Million)
                    5.4. Capsule
                        5.4.1. Capsule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Tablets
                        5.5.1. Tablets Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.6. Others
                        5.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Pharmaceutical Dissolution Testing Services Market: Dissolution Apparatus Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Pharmaceutical Dissolution Testing Services Market Movement Analysis
                    6.3. U.S. Pharmaceutical Dissolution Testing Services Market Size & Trend Analysis, by dissolution apparatus, 2021 to 2033 (USD Million)
                    6.4. Basket
                        6.4.1. Basket Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Paddle
                        6.5.1. Paddle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Others
                        6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Company Categorization
                    7.2. U.S. Pharmaceutical Dissolution Testing Services Market Share Analysis, 2024
                    7.3. Company Profiles
                        7.3.1. Intertek Group Plc.
                            7.3.1.1. Company overview
                            7.3.1.2. Financial performance
                            7.3.1.3. Product benchmarking
                            7.3.1.4. Strategic initiatives
                        7.3.2. Avivia BV
                            7.3.2.1. Company overview
                            7.3.2.2. Financial performance
                            7.3.2.3. Product benchmarking
                            7.3.2.4. Strategic initiatives
                        7.3.3. Almac Group
                            7.3.3.1. Company overview
                            7.3.3.2. Financial performance
                            7.3.3.3. Product benchmarking
                            7.3.3.4. Strategic initiatives
                        7.3.4. Agilent Technologies, Inc.
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Catalent, Inc.
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Thermo Fisher Scientific Inc.
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Cambrex
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Charles River Laboratories
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Boston Analytical
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. Pace Analytical Life Sciences
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. SOTAX
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. AMRI
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. SGS SA
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. pharmaceutical dissolution testing services market estimates and forecasts, by method, 2021 - 2033 (USD Million)
Table 3 U.S. pharmaceutical dissolution testing services market estimates and forecasts, by dosage form, 2021 - 2033 (USD Million)
Table 4 U.S. pharmaceutical dissolution testing services market estimates and forecasts, by dissolution apparatus, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 U.S Pharmaceutical dissolution testing services market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market outlook, 2024 (USD Million)
Fig. 17 Ancillary market outlook, 2024 (USD Million)
Fig. 18 Pharmaceutical dissolution testing services market dynamics
Fig. 19 Total R&D drug pipeline size, 2021-2024
Fig. 20 Total drug pipeline by development phase, 2024
Fig. 21 Porter’s five forces analysis
Fig. 22 PESTEL analysis
Fig. 23 U.S Pharmaceutical dissolution testing services market method outlook: Segment dashboard
Fig. 24 Pharmaceutical dissolution testing services market, by method segment: Market share, 2025 & 2033
Fig. 25 In vitro market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 In vivo market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 U.S Pharmaceutical dissolution testing services market dosage form outlook: Segment dashboard
Fig. 28 Pharmaceutical dissolution testing services market, by dosage form segment: Market share, 2024 & 2033
Fig. 29 Capsule market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Tablets market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 U.S Pharmaceutical dissolution testing services market dissolution apparatus outlook: Segment dashboard
Fig. 33 Pharmaceutical dissolution testing services market, by dissolution apparatus segment: Market share, 2024 & 2033
Fig. 34 Basket market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Paddle market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Market participant categorization
Fig. 37 Heat map analysis